ヒドロキシエチルデンプン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ヒドロキシエチルデンプン" in Japanese language version.

refsWebsite

Global rank Japanese rank

24nih.gov

4^th place

24^th place

18doi.org

2^nd place

6^th place

6europa.eu

68^th place

425^th place

4worldcat.org

5^th place

19^th place

4fda.gov

447^th place

1,043^rd place

2semanticscholar.org

11^th place

1,537^th place

2web.archive.org

1^st place

2nejm.org

2,374^th place

2,486^th place

2federalregister.gov

2,474^th place

9,256^th place

1nii.ac.jp

304^th place

20^th place

1jsicm.org

low place

1kegg.jp

low place

2,161^st place

1pmda.go.jp

6,690^th place

394^th place

1lww.com

2,769^th place

4,586^th place

1oxfordjournals.org

1,389^th place

1,710^th place

1fichier-pdf.fr

low place

1sciencenordic.com

low place

1mhra.gov.uk

low place

1wiley.com

222^nd place

498^th place

doi.org

Westphal, M.; James, M.; Kozek-Langenecker, S.; Stocker, R.; Guidet, B.; Van Aken, H. (2009). “Hydroxyethyl starches: different products--different effects. [Review] [140 refs]”. Anesthesiology 111 (1): 187–202. doi:10.1097/aln.0b013e3181a7ec82. PMID 19512862.
宮尾秀樹「第3世代HES130/0.4/9 ボルベン輸液6%について」『日本臨床麻酔学会誌』第34巻第5号、日本臨床麻酔学会、2014年、788-795頁、CRID 1390001204759657088、doi:10.2199/jjsca.34.788、ISSN 0285-4945。
Zarychanski, R; Abou-Setta, AM; Turgeon, AF; Houston, BL; McIntyre, L; Marshall, JC; Fergusson, DA (Feb 20, 2013). “Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.”. JAMA: The Journal of the American Medical Association 309 (7): 678–88. doi:10.1001/jama.2013.430. PMID 23423413.
Zarychanski, R; Abou-Setta, AM; Turgeon, AF; Houston, BL; McIntyre, L; Marshall, JC; Fergusson, DA (Feb 20, 2013). “Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.”. JAMA: The Journal of the American Medical Association 309 (7): 678–88. doi:10.1001/jama.2013.430. PMID 23423413.
Lewis, Sharon R.; Pritchard, Michael W.; Evans, David Jw; Butler, Andrew R.; Alderson, Phil; Smith, Andrew F.; Roberts, Ian (8 March 2018). “Colloids versus crystalloids for fluid resuscitation in critically ill people”. The Cochrane Database of Systematic Reviews 8: CD000567. doi:10.1002/14651858.CD000567.pub7. ISSN 1469-493X. PMC 6513027. PMID 30073665.
Bork, K. (January 2005). “Pruritus precipitated by hydroxyethyl starch: a review”. British Journal of Dermatology 152 (1): 3–12. doi:10.1111/j.1365-2133.2004.06272.x. PMID 15656795.
Deusch, Engelbert; Thaler, Ulrich; Kozek-Langenecker, Sibylle A. (2004-09). “The Effects of High Molecular Weight Hydroxyethyl Starch Solutions on Platelets:” (英語). Anesthesia & Analgesia 99 (3): 665–668. doi:10.1213/01.ANE.0000130349.99727.58. ISSN 0003-2999.
Brunkhorst FM; Engel C; Bloos F; Meier-Hellmann, Andreas; Ragaller, Max; Weiler, Norbert; Moerer, Onnen; Gruendling, Matthias et al. (January 2008). “Intensive insulin therapy and pentastarch resuscitation in severe sepsis”. N. Engl. J. Med. 358 (2): 125–39. doi:10.1056/NEJMoa070716. PMID 18184958 2022年11月16日閲覧。3
Perner, A.; Haase, N.; Wetterslev, J.; Åneman, A.; Tenhunen, J.; Guttormsen, A. B.; Klemenzson, G. (2011). “Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial”. Trials 12: 24. doi:10.1186/1745-6215-12-24. PMC 3040153. PMID 21269526etal
Downar, James; Lapinsky, Stephen E (29 January 2009). “Pro/con debate: Should synthetic colloids be used in patients with septic shock?”. Critical Care 13 (1): 203. doi:10.1186/cc7147. PMC 2688101. PMID 19226441.
Perner, A.; Haase, N.; Wetterslev, J.; Åneman, A.; Tenhunen, J.; Guttormsen, A. B.; Klemenzson, G. (2011). “Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial”. Trials 12: 24. doi:10.1186/1745-6215-12-24. PMC 3040153. PMID 21269526etal
Hartog, C.; Reinhart, K. (2009). “CONTRA: Hydroxyethyl starch solutions are unsafe in critically ill patients”. Intensive Care Medicine 35 (8): 1337–42. doi:10.1007/s00134-009-1521-5. PMID 19533093.
Westphal, M.; James, M.; Kozek-Langenecker, S.; Stocker, R.; Guidet, B.; Van Aken, H. (2009). “Hydroxyethyl starches: different products--different effects. [Review] [140 refs]”. Anesthesiology 111 (1): 187–202. doi:10.1097/aln.0b013e3181a7ec82. PMID 19512862.
“Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.”. The New England Journal of Medicine 367 (2): 124–34. (July 12, 2012). doi:10.1056/NEJMoa1204242. PMID 22738085.
Myburgh, John A. (2012). “Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care”. N Engl J Med 367 (20): 1901–1911. doi:10.1056/NEJMoa1209759. PMID 23075127etal
Dellinger, R. Phillip; Levy, Mitchell M.; Rhodes, Andrew MB; Annane, Djillali; Gerlach, Herwig; Opal, Steven M.; Sevransky, Jonathan E.; Sprung, Charles L. et al. (February 2013). “Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012”. Critical Care Medicine 41 (2): 580–637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941.
Brunkhorst, Frank M.; Engel, Christoph; Bloos, Frank; Meier-Hellmann, Andreas; Ragaller, Max; Weiler, Norbert; Moerer, Onnen; Gruendling, Matthias et al. (2008-01-10). “Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis” (英語). New England Journal of Medicine 358 (2): 125–139. doi:10.1056/NEJMoa070716. ISSN 0028-4793.
Lewis, Sharon R; Pritchard, Michael W; Evans, David JW; Butler, Andrew R; Alderson, Phil; Smith, Andrew F; Roberts, Ian (2018-08-03). Cochrane Injuries Group. ed. “Colloids versus crystalloids for fluid resuscitation in critically ill people” (英語). Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD000567.pub7. PMC 6513027. PMID 30073665.

europa.eu

ema.europa.eu

“Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients” (Press release). European Medicines Agency. 23 October 2013.
“Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients” (Press release). European Medicines Agency. 23 October 2013.
“PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients” (Press release). Pharmacovigilance Risk Assessment Committee, European Medicines Agency. 11 October 2013.
“European Medicines Agency - Human medicines - Hydroxyethyl starch (HES) containing medicinal products” (英語). www.ema.europa.eu. 2018年1月27日閲覧。
“Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients”. European Medicines Agency (2018年7月17日). 2022年11月16日閲覧。
“Hydroxyethyl-starch solutions for infusion recommended for suspension from the market | European Medicines Agency”. 2022年6月11日閲覧。

fda.gov

federalregister.gov

“Fresenius Kabi Deutschland GmbH; Withdrawal of Approval of New Drug Application of Hydroxyethyl Starch”. Federal Register. 2022年11月26日閲覧。
“B. Braun Medical, Inc.; Withdrawal of Approval of Abbreviated New Drug Application of Hydroxyethyl Starch”. Federal Register. 2022年11月26日閲覧。

fichier-pdf.fr

Søe-Jens, Perner Anders, Haase Nicolai, Guttormsen Anne B. , Tenhunen Jyrki, Klemenzson Gudmundur, Åneman Anders, Madsen Kristian R. , Møller Morten H. , Elkjær Jeanie M. , Poulsen Lone M. , Bendtsen Asger, Winding Robert, Steensen Morten, Berezowicz Pawel. “Fichier PDF NEJM fluids in severe sepsis.pdf” (フランス語). Fichier PDF. 2022年11月17日閲覧。